Tag: Markets/Marketing

Pfizer Squares Off With Merck on Pneumonia Shots

Pfizer Squares Off With Merck on Pneumonia Shots

[ad_1] Rival drugmakers are seeking to upend Pfizer Inc.’s dominance of the $7 billion worldwide market for pneumonia vaccines, launching what is shaping up to be one of the industry’s fiercest battles. Merck & Co. has already introduced a new competitor to Pfizer’s Prevnar vaccine franchise, while GSK PLC and Vaxcyte Inc. are among companies […]

Read More
Tech Is Getting Boring. That's a Good Thing.

Tech Is Getting Boring. That's a Good Thing.

[ad_1] LAGUNA BEACH, Calif.—With their valuations and earnings down, and their guidance gloomy, America’s tech companies have entered a phase when they have to be brutally honest with themselves about what really works. This means executives are trimming staff, moonshots and unprofitable distractions. They’re also deciding what to focus on. It’s a transition away from […]

Read More
Earnings Signal End to Tech Boom

Earnings Signal End to Tech Boom

[ad_1] A week of earnings by big technology companies has been a rout for investors, as recession fears and the strong dollar hit businesses that were thought to be more resilient. And these industry giants warn more pain is ahead. “It’s just hard to see any points of good news on the horizon,” Intel Corp. […]

Read More